People with mild COVID-19 symptoms can book their own test

From today, potential coronavirus patients showing mild symptoms no longer need to book a time through their GPs

The health authorities have made it easier for those showing mild symptoms to be tested for COVID-19.

Moments ago, the Sundhedstyrelsenhealth authority revealed that from today, people living in Denmark can book their own test and avoid being referred by their GPs.

Furthermore, a number of new clinics will be established for patients who require swift testing.

“If you don’t feel ill to the extent that you need to speak with your GP, you can now book a time yourself via coronaprover.dk to see whether you are infected,” said Helene Probst, the deputy head of Sundhedstyrelsen.

Probst said it was important to stay home and isolate yourself – even if you don’t feel too ill – and wait for your test results.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.